NasdaqGM - Delayed Quote USD

908 Devices Inc. (MASS)

5.67 +0.11 (+1.98%)
At close: April 26 at 4:00 PM EDT
5.67 0.00 (0.00%)
After hours: April 26 at 4:20 PM EDT
Key Events
Loading Chart for MASS
DELL
  • Previous Close 5.56
  • Open 5.77
  • Bid 5.64 x 500
  • Ask 5.69 x 500
  • Day's Range 5.54 - 5.79
  • 52 Week Range 4.85 - 12.51
  • Volume 123,454
  • Avg. Volume 163,269
  • Market Cap (intraday) 186.599M
  • Beta (5Y Monthly) 0.93
  • PE Ratio (TTM) --
  • EPS (TTM) -1.13
  • Earnings Date Apr 30, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 15.33

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

908devices.com

230

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MASS

Performance Overview: MASS

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MASS
49.47%
S&P 500
6.92%

1-Year Return

MASS
20.14%
S&P 500
25.26%

3-Year Return

MASS
89.19%
S&P 500
22.00%

5-Year Return

MASS
--
S&P 500
37.49%

Compare To: MASS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MASS

Valuation Measures

Annual
As of 4/27/2024
  • Market Cap

    186.60M

  • Enterprise Value

    46.86M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.64

  • Price/Book (mrq)

    1.13

  • Enterprise Value/Revenue

    0.93

  • Enterprise Value/EBITDA

    -1.38

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -72.47%

  • Return on Assets (ttm)

    -11.99%

  • Return on Equity (ttm)

    -20.44%

  • Revenue (ttm)

    50.23M

  • Net Income Avi to Common (ttm)

    -36.4M

  • Diluted EPS (ttm)

    -1.13

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    145.68M

  • Total Debt/Equity (mrq)

    3.59%

  • Levered Free Cash Flow (ttm)

    -14.85M

Research Analysis: MASS

Analyst Price Targets

14.00
15.33 Average
5.67 Current
17.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: MASS

Fair Value

5.67 Current
 

Dividend Score

0 Low
MASS
Sector Avg.
100 High
 

Hiring Score

0 Low
MASS
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
MASS
Sector Avg.
100 High
 

People Also Watch